SCHEMBL7737588

SCHEMBL7737588

CCOC(=O)CC1(C(=O)OCC)Cc2ccccc2C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
BRD4 O60885 1/20 0.42
GAA P10253 3/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 2/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MPI P34949 1/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NOTUM Q6P988 1/20 0.39
TSHR P16473 1/20 0.39
OPRM1 P35372 2/20 0.39
SLC22A1 O15245 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9344178 0.87 ALDH1A1 (0.42) ALDH1A1BRD4GAALMNAHPGD
SCHEMBL27188920 0.85 BRD4 (0.43) ALDH1A1BRD4GAAMAPTLMNA
SCHEMBL16153701 0.85 ALDH1A1 (0.41) ALDH1A1BRD4GAAMAPTHPGD
SCHEMBL13923793 0.83 BRD4 (0.41) ALDH1A1BRD4GAAMAPTLMNA
SCHEMBL9937345 0.83 OPRM1 (0.39) ALDH1A1BRD4GAAMAPTLMNA
SCHEMBL6250430 0.81 ALDH1A1 (0.44) ALDH1A1GAAMAPTLMNAHPGD
SCHEMBL15016426 0.80 NPC1 (0.40) ALDH1A1MAPTHPGDSMN1; SMN2MEN1
SCHEMBL1990722 0.80 BRD4 (0.45) ALDH1A1BRD4GAAMAPTLMNA
SCHEMBL9344111 0.79 ALDH1A1 (0.42) ALDH1A1BRD4GAALMNAHPGD
SCHEMBL19838777 0.78 BRD4 (0.52) ALDH1A1BRD4GAAMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699909-B1 MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS PRESCIENT NEUROPHARMA INC. (CA) 2004-03-02 US disclosed